- Home
- BRID vs CRVO Comparison
BRID vs CRVO Comparison
Compare BRID & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRID
- CRVO
- Stock Information
- Founded
- BRID 1932
- CRVO 2001
- Country
- BRID United States
- CRVO United States
- Employees
- BRID N/A
- CRVO N/A
- Industry
- BRID Specialty Foods
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- BRID Consumer Staples
- CRVO Health Care
- Exchange
- BRID Nasdaq
- CRVO Nasdaq
- Market Cap
- BRID 70.3M
- CRVO 67.4M
- IPO Year
- BRID N/A
- CRVO N/A
- Fundamental
- Price
- BRID N/A
- CRVO $5.80
- Analyst Decision
- BRID
- CRVO Strong Buy
- Analyst Count
- BRID 0
- CRVO 8
- Target Price
- BRID N/A
- CRVO $25.57
- AVG Volume (30 Days)
- BRID 5.5K
- CRVO 139.4K
- Earning Date
- BRID 08-22-2025
- CRVO 08-08-2025
- Dividend Yield
- BRID N/A
- CRVO N/A
- EPS Growth
- BRID N/A
- CRVO N/A
- EPS
- BRID N/A
- CRVO N/A
- Revenue
- BRID $224,673,000.00
- CRVO $9,308,215.00
- Revenue This Year
- BRID N/A
- CRVO N/A
- Revenue Next Year
- BRID N/A
- CRVO N/A
- P/E Ratio
- BRID N/A
- CRVO N/A
- Revenue Growth
- BRID N/A
- CRVO 15.14
- 52 Week Low
- BRID $7.50
- CRVO $1.80
- 52 Week High
- BRID $14.69
- CRVO $20.63
- Technical
- Relative Strength Index (RSI)
- BRID 50.67
- CRVO 32.36
- Support Level
- BRID $7.78
- CRVO $6.31
- Resistance Level
- BRID $8.74
- CRVO $7.20
- Average True Range (ATR)
- BRID 0.22
- CRVO 0.52
- MACD
- BRID 0.01
- CRVO -0.10
- Stochastic Oscillator
- BRID 34.68
- CRVO 9.20
About BRID Bridgford Foods Corporation
Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The business segments are; the processing and distribution of frozen products, and the processing and distribution of snack food products. Its product offerings include meat snacks, breads and rolls, biscuits, and ready-to-eat sandwiches among others. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, and mass merchandise and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. A majority of the company's revenue is derived from the snack food products segment.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.